FDA Investigator Christine A Harman, PhD
Christine A Harman, PhD has inspections in 6 countries as of 30 Jun 2023. Christine A Harman, PhD has collaborated with a combinined 3107 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
16
Last Inspection Date:
30 Jun 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
Netherlands,
United States of America,
Israel,
United Kingdom of Great Britain and Northern Ireland,
Spain,
Hungary
Co-Investigator(s):
Alexander M Kay,
Alexey Khrenov, PhD,
Andrew A Hoopes,
Andrew Byrnes, PhD,
Andrew W Harmon,
Angela K Shen,
Anita Narula, PhD,
Ann Marie Montemurro,
Ann Marie Schofield,
Anthony R Bucks,
Ashar P Parikh,
Ashley A Mutawakkil,
Astrida B Mattson,
Barbara Janine Breithaupt,
Bradley Dworak, PhD,
Brandon L Mariner,
Brentley S Collins,
Brett R Havranek,
Brian D Nicholson,
Brittany D Terhar,
Bruce D Meade,
Burnell M Henry,
Carl A Huffman, III,
Caryn M Mcnab,
CDR Donald Ertel,
Christian D Lynch (CDL),
Christopher R Czajka,
Cody D Rickman,
Connie P Rezendes,
Connie P Rezenes,
Cynthia J Lee, MS,
Cynthia Jim, CSO,
Cynthia L Kelley,
Damaris Y Hernandez,
David E Bailey,
David J Eide,
David M Beltram,
David M Beltran,
Dawn E Barkans,
Deborah M Trout,
Derya C Coursey,
Dolores E Price,
Don H Bark, PhD,
Donald L Myers,
Edwin Melendez,
Eileen A Liu,
Elizabeth C Lessey Morillon,
Ellen Huang,
Emmanuel Adu Gyamfi,
Eric M Mueller, PharmD,
Eric M Padgett,
Eric Peng,
Francis A Guidry,
Gene D Arcy,
Gerard Pde Leon,
Gloria J Baca, MS,
Gwyn G Dickinson,
Hector A Carrero,
Heika R Bounds,
Heika R Tait,
Helen B Ricalde,
Helen Y Saccone,
Holly Brevig,
Jacqueline Mdiaz Albertine,
Jacqueline Mdiaz Albertini,
James A Jagon,
James E Keller, PhD,
James I Giefer,
James R Evans,
Janet B Abt,
Jazmine N Still,
Jean Lhu Primmer,
Jennifer L Bridgewater,
Jin Gao,
Joan Johnson,
Joey V Quitania,
Joseph George,
Joseph R Lambert,
Julie D Bringger,
Kari M Johansen,
Kathryn A Krentz,
Kelley,
Kelly K Nachtigal,
Ken L Bowers,
Kenneth O Gee, PhD,
Kevin D Kallander,
Kristin M Abaonza,
Laurel A Beer,
LCDR Debra Emerson,
Lilia L Bi,
Linda Thai,
Lisa K Capron,
Lisa P Oakes,
Lisa Pierce Oakes,
Lori P Peters,
Lynda L Perry, PhD,
Margaret A Smithers,
Maria Pkelly Doggett, MBA,
Marijo B Kambere, PhD,
Marion Michaelis,
Marissa S Steinhagen,
Mariza M Jafary,
Mark W Babbitt,
Marlene L Davis,
Marsha W Major,
Maryna C Eichelberger, PhD,
Matthew M Schuckmann,
Matthew R Sleeter,
Maxine H Wong,
Michael R Goga,
Michele L Forster, PhD,
Michele L Obert,
Michele Perry Williams,
Mihaly S Ligmond,
Mikel T Wright,
Mindy M Chou,
Miriam M Ngundi,
Monica M Mcclure,
Mra Mcculloughj,
Myra K Casey,
Nancy G Schmidt,
Natalya M Ananyeva,
Nawab A Siddiqui,
Omotunde O Osunsanmi,
Ou Ma,
Patsy J Domingo,
Paula A Trost,
Prabhu P Raju,
Pratik S Upadhyay, DDC,
Quyen T Tran,
Ralph H Vocque,
Randy L Self,
Rebecca Rodriguez,
Reginald D Neal,
Richard Heath Coats,
Richard L Rutherford,
Rita K Kabaso,
Robert C Coleman,
Robert D Tollefsen,
Robert J Ham,
Roger F Zabinski,
Rose M Ashley,
S Lori Brown, PhD MPH,
Sangeeta M Khurana, PhD,
Sangeeta M Rataul,
Sarah E Rhoades,
Scott A Golladay,
Scott E Norris,
Sean R Bryd,
Shafiq S Ahadi,
Shirley J Berryman,
Sidney B Priesmeyer,
Simone E Pitts,
Steven C Derrick,
Steven D Kehoe,
Steven P Donald,
Sukhanya Jayachandra,
Susan F Laska, MS,
Susan M Jackson,
Susan Yu,
Susanna E Ford, Analyst,
Tara L Breckenridge,
Tara L Greene,
Terri L Dodds,
Terry L Dodds,
Thomas J Arista,
Tina S Roecklein,
Tracy K Li,
Uttaniti Limchumroon (Tom),
Walsworth,
Wei Wang, PhD,
William D Tingley,
Xiomara Copeland,
Yiping Jia,
Zi Qiang Gu
Christine A Harman, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2016 | FDA 483 | SynCo Bio Partners Bv - Form 483, 2016-04-06 |
June, 2019 | EIR | Jubilant HollisterStier LLC - EIR, 2019-06-14 |
September, 2014 | FDA 483 | Nova Laboratories Ltd - Form 483, 2014-09-29 |
February, 2018 | FDA 483 | Symbiosis Pharmaceutical Services Limited - Form 483, 2018-02-23 |
June, 2019 | FDA 483 Response | Jubilant HollisterStier LLC - Form 483R, 2019-07-02 |
June, 2019 | FDA 483 | Jubilant HollisterStier LLC - Form 483, 2019-06-14 |
March, 2017 | FDA 483 | Instituto Grifols, S.A. - Form 483, 2017-03-24 |
October, 2019 | FDA 483 | Emergent Biodefense Operations Lansing LLC - Form 483, 2019-10-04 |
September, 2023 | FDA 483 | Minaris Regenerative Medicine, LLC - Form 483, 2023-09-25 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more